# ADRENALIN
> **NDA215875** · New Drug Application · Sponsor: PH HEALTH · Approved 2023-04-21
## Drug
- **FDA Application Number:** NDA215875
- **Application type:** New Drug Application
- **Brand name:** ADRENALIN
- **Generic name:** EPINEPHRINE IN SODIUM CHLORIDE
- **Active ingredients:** EPINEPHRINE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** PH HEALTH
- **Manufacturer:** Par Health USA, LLC
- **First approval:** 2023-04-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215875)
---
*MORVS · CC0 1.0*